Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 301–400 of 1,002
Hsieh, R.-Y., Huang, I.-C., Chen, C., & Sung, J. (2023) · Nutrients · doi:10.3390/nu15163634 · Cited by 80
“Decreased CNFD and CNFL can diagnose DSPN early [40,41].”
Prediabetic Neuropathy: Does It Exist?
Παπάνας, Ν., & Ziegler, D. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0278-3 · Cited by 82
Physiology in Medicine: neuromuscular consequences of diabetic neuropathy
Allen, M. D., Doherty, T. J., Rice, C. L., & Kimpinski, K. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00733.2015 · Cited by 82
Mao, F., Liu, S., Qiao, X., Zheng, H., Xiong, Q., Wen, J., Liu, L., Tang, M., Zhang, S., Zhang, Z., et al. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12575 · Cited by 66
Truini, A., Biasiotta, A., Stefano, G. D., Leone, C. M., Cesa, S. L., Galosi, E., Piroso, S., Pepe, A., Giordano, C., & Cruccu, G. (2014) · Pain · doi:10.1016/j.pain.2014.01.022 · Cited by 65
Charles, M., Fleischer, J., Witte, D. R., Ejskjær, N., Borch‐Johnsen, K., Lauritzen, T., & Sandbæk, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2744-5 · Cited by 66
“As two abnormal tests are sufficient for a diagnosis of CAN [7], we chose to include all participants with at least two complete tests, yielding a study sample of 777 participants in this analysis.”
Prediabetes/early diabetes‐associated neuropathy predominantly involves sensory small fibres
Divišová, Š., Vlčková, E., Hnojčíková, M., Škorňa, M., Němec, M., Dubový, P., Dušek, L., Jarkovský, J., Bělobrádková, J., & Bednařík, J. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00420.x · Cited by 68
“If we compare the Tesfaye et al. criteria for DSPN (Tesfaye et al., 2010) and those for SFN from Malik et al. (2011), the category of definite SFN becomes more restrictive (symptoms + signs + abnormality of IENFD and/or TPT) compared to confirmed DSPN (symptom or sign + abnormality of NC or SFN…”
BackgroundMethodResultInfluentialHigh resolution ultrasonography of the tibial nerve in diabetic peripheral neuropathy
Singh, K., Gupta, K., & Kaur, S. (2017) · Journal of Ultrasonography · doi:10.15557/jou.2017.0036 · Cited by 65
Perkins, B. A., Lovblom, L. E., Lewis, E. J. H., Bril, V., Ferdousi, M., Orszag, A., Edwards, K. P., Pritchard, N., Russell, A. W., Dehghani, C., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0476 · Cited by 64
Self-citationThe Treatment of Painful Diabetic Neuropathy
SLOAN, G. P., Alam, U., Selvarajah, D., & Tesfaye, S. H. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210707112413 · Cited by 71
Self-citationZhu, T., Meng, Q., Ji, J., Lou, X., & Zhang, L. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.11.020 · Cited by 64
Dehghani, C., Pritchard, N., Edwards, K. P., Vagenas, D., Russell, A. W., Malik, R. A., & Efron, N. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15605 · Cited by 64
Self-citationFarmer, A. D., Pedersen, A. G., Brock, B., Jakobsen, P. E., Karmisholt, J., Mohammed, S. D., Scott, S. M., Drewes, A. M., & Brock, C. (2017) · Diabetologia · doi:10.1007/s00125-016-4199-6 · Cited by 65
“DAN and DSPN are thought to share a common pathophysiology and therefore frequently coexist in the same patient [23].”
BackgroundInfluentialChow, E., Bernjak, A., Walkinshaw, E., Lubina-Solomon, A., Freeman, J., Macdonald, I. A., Sheridan, P. J., & Heller, S. R. (2017) · Diabetes · doi:10.2337/db16-1310 · Cited by 63
“6 Cardiovascular autonomic reflex tests were performed as previously described (10) following a recent consensus statement (11).”
Lovshin, J. A., Bjornstad, P., Lovblom, L. E., Bai, J.-W., Lytvyn, Y., Boulet, G., Farooqi, M. A., Santiago, S., Orszag, A., Scarr, D., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1236 · Cited by 63
Diabetic Peripheral Neuropathy: Diagnosis and Treatment
Røikjer, J., Mørch, C. D., & Ejskjær, N. (2020) · Current Drug Safety · doi:10.2174/1574886315666200731173113 · Cited by 79
“Early detection and monitoring of DPN are recommended in most clinical guidelines, including consensus statements from the Toronto Diabetic Neuropathy Expert Group [10] and the American Diabetes Association [11].”
Machine learning algorithm to evaluate risk factors of diabetic foot ulcers and its severity
Nanda, R., Nath, A., Patel, S., & Mohapatra, E. (2022) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-022-02617-w · Cited by 70
Corneal Markers of Diabetic Neuropathy
Pritchard, N., Edwards, K. P., Shahidi, A. M., Sampson, G. P., Russell, A. W., Malik, R. A., & Efron, N. (2011) · The Ocular Surface · doi:10.1016/s1542-0124(11)70006-4 · Cited by 65
Self-citationGuidelines in the management of diabetic nerve pain clinical utility of pregabalin
Vinik, A., & Casellini (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s24825 · Cited by 63
“Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 metabolic and microvascular alterations as a result of chronic hyperglycemia exposure (diabetes) and cardiovascular risk covariates.(3) Its onset is generally insidious, and without treatment its course is chronic and progressive.”
Self-citationTessaro, F. H. G., Ayala, T. S., & Martins, J. O. (2015) · BioMed Research International · doi:10.1155/2015/568408 · Cited by 70
Lovblom, L. E., Halpern, E. M., Wu, T., Kelly, D., Ahmed, A., Boulet, G., Orszag, A., Ng, E., Ngo, M., Bril, V., et al. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.02.006 · Cited by 65
Væggemose, M., Pham, M., Ringgaard, S., Tankişi, H., Ejskjær, N., Heiland, S., Poulsen, P. L., & Andersen, H. (2017) · Diabetes · doi:10.2337/db16-1049 · Cited by 63
Nascimento, O. J. M., Pupe, C., & Cavalcanti, E. B. U. (2016) · Revista Dor · doi:10.5935/1806-0013.20160047 · Cited by 69
Morgenstern, J., Groener, J. B., Jende, J. M. E., Kurz, F. T., Strom, A., Göpfert, J. C., Κender, Ζ., Marois, M. L., Brune, M., Kuner, R., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05557-6 · Cited by 68
Strategies for preventing type 2 diabetes: an update for clinicians
Khavandi, K., Amer, H., Ibrahim, B., & Brownrigg, J. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313494986 · Cited by 62
“There is a particularly strong association between prediabetes and autonomic neuropathy, with consistent reports of disordered parasympathetic function [Tesfaye et al. 2010; Wu et al. 2007; Putz et al. 2009] and sensory neuropathy [HoffmanSnyder et al.”
BackgroundManagement of Painful Diabetic Neuropathy: Guideline Guidance or Jungle?
Spallone, V. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0287-2 · Cited by 71
Self-citationZhou, L. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1688977 · Cited by 65
Huang, H., Qiu, M. R., Lin, J., Li, M.-Q., Ma, X., Ran, F., Luo, C., Wei, X., Xu, R., Tan, P., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-020-02471-2 · Cited by 63
Zheng, T., Wang, Q., Bian, F., Zhao, Y., Ma, W., Zhang, Y., Lu, W., Pan, L., Zhang, L., Hao, X., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115468 · Cited by 62
The Glenn A. Fry Award Lecture 2010: Ophthalmic Markers of Diabetic Neuropathy
Efron, N. (2011) · Optometry and Vision Science · doi:10.1097/opx.0b013e3182171020 · Cited by 62
Dohrn, M. F., Othman, A., Hirshman, S., Bode, H., Alecu, I., Fähndrich, E., Karges, W., Weis, J., Schulz, J. B., Hornemann, T., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12663 · Cited by 61
“The DSPN group consisted of 39 patients with T2DM and a polyneuropathy, which was clinically and electroneurographically characterized by a symmetrical, length-dependent distribution and a predominantly sensory involvement, corresponding to DSPN [4].”
BackgroundXu, Q., Pan, J., Yu, J., Liu, X., Liu, L., Zuo, X., Wu, P., Deng, H., Zhang, J., & Ji, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.033 · Cited by 65
“[5] Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al.”
BackgroundKostev, K., Jockwig, A., Hallwachs, A. J., & Rathmann, W. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.01.011 · Cited by 62
Small fiber neuropathy: a disabling and underrecognized syndrome
Voortman, M., Fritz, D., Vogels, O. J. M., Eftimov, F., van de Beek, D., Brouwer, M. C., & Drent, M. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000413 · Cited by 74
Gregory, J. A., Jolivalt, C. G., GOOR, J. C. V., Mizisin, A. P., & Calcutt, N. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1012-6 · Cited by 70
“Early physiological disorders such as nerve conduction slowing and sensory loss can be used to diagnose and stage diabetic neuropathy [52] and may predict onset of, then reflect, degenerative changes in neurons, Schwann cells and blood vessels.”
Tang, Y., Shah, H., Bueno Junior, C. R., Sun, X., Mitri, J., Sambataro, M., Sambado, L., Gerstein, H. C., Fonseca, V., Doria, A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1842 · Cited by 60
Recent advances in exploring the genetic susceptibility to diabetic neuropathy
Politi, C., Ciccacci, C., D’Amato, C., Novelli, G., Borgiani, P., & Spallone, V. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.08.006 · Cited by 63
Self-citationPainful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management
Preston, F., Riley, D. R. J., Azmi, S., & Alam, U. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s370050 · Cited by 70
“The most prevalent form is diabetic peripheral neuropathy (DPN), a symmetrical, length-dependent sensorimotor polyneuropathy.(5) DPN typically presents in a “stocking and glove” distribution,”
BackgroundCorneal confocal microscopy: Recent progress in the evaluation of diabetic neuropathy
Παπάνας, Ν., & Ziegler, D. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12335 · Cited by 61
Diagnostic accuracy of laser-evoked potentials in diabetic neuropathy
Stefano, G. D., Cesa, S. L., Leone, C. M., Pepe, A., Galosi, E., Fiorelli, M., Valeriani, M., Lacerenza, M. R., Pergolini, M., Biasiotta, A., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000889 · Cited by 86
Fridman, V., Zarini, S., Sillau, S., Harrison, K. A., Bergman, B. C., Feldman, E. L., Reusch, J. E. B., & Callaghan, B. C. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107852 · Cited by 64
Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., McKnight, J. M., Green, F., Collier, A., McKeigue, P. M., & Colhoun, H. M. (2020) · Diabetes Care · doi:10.2337/dc19-1582 · Cited by 59
Improving assessment in small fiber neuropathy
Brouwer, B. A., Bakkers, M., Hoeijmakers, J. G. J., Faber, C. G., & Merkies, I. S. J. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12128 · Cited by 66
“All participants fulfilled the international criteria for SFN (Tesfaye et al., 2010; Lauria et al., 2012).”
BackgroundYu, X., Zhang, L., Yang, X., Huang, H., Huang, Z., Shi, L., Zhang, H., & Du, G. (2012) · Molecules · doi:10.3390/molecules170911216 · Cited by 59
“Implementation of intensive glycaemic control and symptomatic therapy shows modest efficacy in the clinic [2].”
BackgroundCho, Y. R., Lim, J. H., Kim, M. Y., Kim, T. W., Hong, B. Y., Kim, Y., Chang, Y. S., Kim, H. W., & Park, C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083204 · Cited by 59
Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance
Dimova, R. B., Tankova, T. I., Guergueltcheva, V., Tournev, I., Chakarova, N. Y., Grozeva, G. G., & Dakovska, L. N. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.11.002 · Cited by 67
Li, L., Sheng, X., Zhao, S., Zou, L., Han, X., Gong, Y., Yuan, H., Shi, L., Guo, L., Jia, T., et al. (2017) · Purinergic Signalling · doi:10.1007/s11302-017-9583-2 · Cited by 59
Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients
Moțățăianu, A., Maier, S., Bajkó, Z., Voidăzan, S. T., Bălașa, R., & Stoian, A. (2018) · BMC Neurology · doi:10.1186/s12883-018-1125-1 · Cited by 62
Elliott, D., SLOAN, G. P., Stevens, L. K., Selvarajah, D., Cruccu, G., Gandhi, R. A., Kempler, P., Fuller, J., Chaturvedi, N., Tesfaye, S. H., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06025-z · Cited by 70
“A strength of our study is the robust detection of painful DPN, using the presence of common neuropathic pain symptoms in the presence of confirmed DPN using neurophysiological tests [39].”
MethodSelf-citationAtmaca, A. A., Ketenci, A., Şahin, İ., Şengün, İ. Ş., Öner, R. İ., Tilki, H. E., Adaş, M., Soyleli, H., & Demir, T. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1380929 · Cited by 69
The Conductor of the Autonomic Orchestra
Vinik, A. I. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00071 · Cited by 67
“In fact, it is one of the only drugs targeting the nervous system to be endorsed by the Toronto consensus (Tesfaye et al., 2010).”
BackgroundSelf-citationHernández-Ojeda, J., Cardona-Muñóz, E. G., Román-Pintos, L. M., Troyo‐Sanromán, R., Ortiz‐Lazareno, P. C., Cárdenas-Meza, M. A., Pascoe-González, S., & Miranda‐Díaz, A. G. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.04.004 · Cited by 62
Diabetic cardiovascular autonomic neuropathy: clinical implications
Karayannis, G., Giamouzis, G., Cokkinos, D. V., Skoularigis, J. S., & Triposkiadis, F. K. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.53 · Cited by 64
Pan, Q., Li, Q., Deng, W., Zhao, D., Qi, L., Huang, W., Ma, L., Li, H., Li, Y., Lyu, X., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00617 · Cited by 61
“After 2010, an active diagnosis based on symptoms, signs and neurological functions was recommended, which is more stringent diagnostic criteria (9).”
MethodMechanism of the JAK2/STAT3-CAV-1-NR2B signaling pathway in painful diabetic neuropathy
Chuan-da, L., Zhao, J., Chen, J., Lu, J., Zhang, M., Huang, Q., Cao, Y., Jia, G., Tao, Y., Li, J., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01880-6 · Cited by 60
Diabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 69
Hu, Y.-M., Zhao, L.-H., Zhang, X.-L., Cai, H.-L., Huang, H.-Y., Xu, F., Chen, T., Wang, X.-Q., Guo, A.-S., Li, J.-A., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1546-z · Cited by 57
The Role of Biofactors in Diabetic Microvascular Complications
Ziegler, D., Porta, M., Παπάνας, Ν., Moța, M., Jermendy, G., Beltramo, E., Mazzeo, A., Caccioppo, A., Striglia, E., Serhiyenko, V. A., et al. (2021) · Current Diabetes Reviews · doi:10.2174/1871527320666210825112240 · Cited by 61
Self-citationBaskozos, G., Themistocleous, A. C., Hébert, H. L., Pascal, M. M. V., John, J., Callaghan, B. C., Laycock, H. C., Granovsky, Y., Crombez, G., Yarnitsky, D., et al. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01890-x · Cited by 61
“For the training datasets one or more physicians have defined phenotypes after detailed clinical examination and grading of neuropathic pain as discussed above and in line with IASP and NeuPSIG definitions [47, 53].”
Clinical and nerve conduction study correlation in patients of diabetic neuropathy.
Kakrani, A. L., Gokhale, V. S., Vohra, K. V., & Chaudhary, N. (2014) · PubMed · Cited by 72
Worthington, A., Alam, U., Themistocleous, A. C., Calcutt, N. A., & Marshall, A. G. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.03.020 · Cited by 61
Picon, A. P., Ortega, N. R. S., Watari, R., Sartor, C. D., & Sacco, I. D. C. N. (2012) · Clinics · doi:10.6061/clinics/2012(02)10 · Cited by 56
Pharmacotherapy of autonomic failure
Shibao, C. A., Okamoto, L. E., & Biaggioni, I. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.009 · Cited by 56
“The classical presentation of DAN is the patient who has inadequate glycemic control and has other complications associated with diabetes, particularly polyneuropathy, nephropathy and retinopathy (Tesfaye et al., 2010).”
BackgroundMantovani, A., Rigolon, R., Mingolla, L., Pichiri, I., Cavalieri, V., Salvotelli, L., Stoico, V., Zoppini, G., Bonora, E., & Targher, G. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.024 · Cited by 56
Mao, F., Zhu, X., Liu, S., Qiao, X., Zheng, H., Lü, B., & Li, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.0618 · Cited by 56
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy [3].”
BackgroundDiabetic peripheral neuropathy in people with type 2 diabetes: too little too late
Javed, S., Hayat, T., Menon, L., Alam, U., & Malik, R. A. (2019) · Diabetic Medicine · doi:10.1111/dme.14194 · Cited by 65
Self-citationCutaneous pain in disorders affecting peripheral nerves
Stucky, C. L., & Mikesell, A. R. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136233 · Cited by 60
Neuromuscular ultrasound in polyneuropathies and motor neuron disease
Hobson‐Webb, L. D. (2012) · Muscle & Nerve · doi:10.1002/mus.23737 · Cited by 55
Morphometry of dermal nerve fibers in human skin
Lauria, G., Cazzato, D., Porretta‐Serapiglia, C., Casanova‐Mollá, J., Taiana, M. M., Penza, P., Lombardi, R., Faber, C. G., & Merkies, I. S. J. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab51 · Cited by 57
Self-citationDavidson, E. P., Coppey, L. J., Holmes, A. J., & Yorek, M. A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8806 · Cited by 55
Stem, M. S., Hussain, M., Lentz, S. I., Raval, N., Gardner, T. W., Pop‐Busui, R., & Shtein, R. M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.007 · Cited by 61
Kamenov, Z. A., & Traykov, L. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_15 · Cited by 58
Gylfadottir, S. S., Itani, M., Krøigård, T., Kristensen, A. G., Christensen, D. H., Nicolaisen, S. K., Karlsson, P., Callaghan, B. C., Bennett, D., Andersen, H., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14469 · Cited by 60
Perioperative management of adult diabetic patients. Preoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.020 · Cited by 66
Self-citationFerdousi, M., Kalteniece, A., Petropoulos, I. N., Azmi, S., Dhage, S. S., Marshall, A. G., Boulton, A. J. M., Efron, N., Faber, C. G., Lauria, G., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.3.48 · Cited by 54
Self-citationFranceschi, R., Mozzillo, E., Candia, F. D., Rosanio, F. M., Leonardi, L., Liguori, A., Micheli, F., Cauvin, V., Franzese, A., Piona, C. A., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01850-x · Cited by 58
“Electromyography (EMG) and Nerve conduction velocity (NCV) of two or more nerves are the gold standard to confirm DPN diagnosis [4].”
BackgroundD'Souza, R. S., Kubrova, E., Her, Y. F., Barman, R. A., Smith, B. J., Alvarez, G. A. M., West, T., & Abd-Elsayed, A. A. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02244-9 · Cited by 56
“Painful Diabetic Neuropathy Painful diabetic neuropathy (PDN) is defined as a symmetric, length-dependent sensorimotor polyneuropathy attributable to metabolic and microvascular alterations as a result of chronic hyperglycemia exposure and cardiovascular risk covariates [43].”
BackgroundXu, W., Zhu, Y., Yang, X., Deng, H., Yan, J., Lin, S., Yang, H.-Z., Chen, H., & Weng, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.078 · Cited by 57
Wherefore Art Thou, O Treatment for Diabetic Neuropathy?
Malik, R. A. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.008 · Cited by 55
Self-citationCosson, E., Catargi, B., Cheisson, G., Jacqueminet, S., Ichaï, C., Leguerrier, A.-M., Ouattara, A., Tauveron, I., Bismuth, É., Benhamou, D., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.014 · Cited by 56
“The current recommendations suggest carrying out these tests in patients with known T1D of at least 5 years’ standing and in all T2D patients, particularly those with microangiopathic complications [40].”
Self-citationPeripheral Neuropathy as a Component of Skeletal Disease in Diabetes
Beeve, A. T., Brazill, J. M., & Scheller, E. L. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00528-8 · Cited by 59
Verdugo, R. J., Matamala, J. M., Inui, K., Kakigi, R., Valls‐Solé, J., Hansson, P. T., Nilsen, K. B., Lombardi, R., Lauria, G., Petropoulos, I. N., et al. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2022.01.002 · Cited by 78
“,stocking and glove distribution, and may associate to allodynia and hyperalgesia (Tesfaye et al. 2010; Lolignier et al. 2015).”
Self-citationThe conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 66
Rivera, A. L., Estañol, B., Sentíes-Madrid, H., Fossión, R., Toledo-Roy, J. C., Mendoza-Temis, J., Morales, I. O., Landa, E., Robles-Cabrera, A., Moreno, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148378 · Cited by 53
“HRV has a temporal structure with robust long-range correlations, fractal and non-linear features, which have been found to break down under pathologic conditions like DM, reflecting changes in the neuro-autonomic control mechanisms [3, 16, 17].”
BackgroundLi, R., Ma, J., Wu, Y., Nangle, M. R., Zou, S., Li, Y., Yin, J., Zhao, Y., Xu, H., Zhang, H., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.18636 · Cited by 53
“and decreased sensation, and can negatively influence quality of life [3].”
BackgroundHansen, C. S., Vistisen, D., Jørgensen, M. E., Witte, D. R., Brunner, E. J., Tabák, Á. G., Mika Kivimaki, B., Roden, M., Malík, M., & Herder, C. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0634-3 · Cited by 53
Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review
Shabeeb, D., Najafi, M., Hasanzadeh, G., Hadian, M. R., Musa, A., & Shirazi, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.026 · Cited by 54
Herder, C., Kannenberg, J. M., Carstensen‐Kirberg, M., Strom, A., Bönhof, G. J., Rathmann, W., Huth, C., Köenig, W., Heier, M., Krumsiek, J., et al. (2018) · Diabetes · doi:10.2337/db18-0060 · Cited by 61
Zhang, Y., Qu, M., Yi, X., Zhuo, P., Tang, J., Chen, X., Zhou, G., Hu, P., Qiu, T. H., Xing, W., et al. (2019) · Human Brain Mapping · doi:10.1002/hbm.24834 · Cited by 54
“…in a cohort of Type 2 diabetic patients with peripheral neuropathy (further divided into subgroups of painful and painless DPN due to their disparate disease stages, treatment options and prognoses [Sorensen, Molyneaux, & Yue, 2006; Tesfaye et al., 2010]), compared with healthy controls (HCs).”
BackgroundProgression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes
Yun, J., Park, Y., Cha, S., Ahn, Y., & Ko, S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0752-6 · Cited by 55
Scoring systems to screen for diabetic peripheral neuropathy
Yang, Z., Chen, R., Zhang, Y., Huang, Y., Hong, T., Sun, F., Ji, L., & Zhan, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010974 · Cited by 61
RetractedCorrelates of muscle strength in diabetes
Balducci, S., Sacchetti, M., Orlando, G., Salvi, L., Pugliese, L., Salerno, G., D’Errico, V., Iacobini, C., Conti, F., Zanuso, S., et al. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.010 · Cited by 58
The diagnostic accuracy of Neuropad® for assessing large and small fibre diabetic neuropathy
Ponirakis, G., Petropoulos, I. N., Fadavi, H., Alam, U., Asghar, O., Marshall, A. G., Tavakoli, M., & Malik, R. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12536 · Cited by 53
Self-citationSalvi, L., Plateroti, P., Balducci, S., Bollanti, L., Conti, F., Vitale, M., Recupero, S. M., Enrici, M. M., Fenicia, V., & Pugliese, G. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.025 · Cited by 58
Gender differences in quality of life in adults with long-standing type 1 diabetes mellitus
Castellano-Guerrero, A. M., Guerrero, R., Ruiz-Aranda, D., Perea, S. H., Pumar, A., Relimpio, F., Mangas, M. Á., Losada, F., & Martínez‐Brocca, M. A. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00571-x · Cited by 56
Effect of Glycemic Control on Sudomotor Denervation in Type 2 Diabetes
Luo, K., Chao, C., Hsieh, P.-C., Lue, J., & Hsieh, S. (2012) · Diabetes Care · doi:10.2337/dc11-1607 · Cited by 53
on behalf of the FREMS European Trial Study Group, Bosi, E., Bax, G., Scionti, L., Spallone, V., Tesfaye, S. H., Valensi, P. E., & Ziegler, D. (2012) · Diabetologia · doi:10.1007/s00125-012-2795-7 · Cited by 55
“Peripheral diabetic neuropathy is a common and potentially disabling complication affecting a significant proportion of patients with either type 1 or type 2 diabetes [1].”
BackgroundSelf-citationBorbjerg, M. K., Wegeberg, A., Nikontovic, A., Mørch, C. D., Arendt‐Nielsen, L., Ejskjær, N., Brock, C., Vestergaard, P., & Røikjer, J. (2025) · Diabetes Care · doi:10.2337/dc24-2287 · Cited by 52
Utsunomiya, T., Nagaoka, T., Hanada, K., Omae, T., Yokota, H., Abiko, A., Haneda, M., & Yoshida, A. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16609 · Cited by 51
F‐wave latencies in patients with diabetes mellitus
Pan, H., Jian, F., Lin, J., Chen, N., Zhang, C., Zhang, Z., Ding, Z., Wang, Y., Cui, L., & Kimura, J. (2013) · Muscle & Nerve · doi:10.1002/mus.24127 · Cited by 51
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.